Alterations in regulatory T cells and immune checkpoint molecules in pancreatic cancer patients receiving FOLFIRINOX or gemcitabine plus nab-paclitaxel

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: "L. Sams,#1 S. Kruger,#1 V. Heinemann,1,2 D. Bararia,3 S. Haebe,1,3 S. Alig,1,3 M. Haas,1 D. Zhang,1 C. B. Westphalen,1 S. Ormanns,4 P. Metzger,5 J. Werner,6 O. Weigert,1,2,3 M. von Bergwelt-Baildon,1,2 F. Rataj,5 S. Kobold,2,5 and S. Boeck"

Journal title: Clinical and Translational Oncology

Journal publisher: Doyma

Published year: 2021

DOI identifier: 10.1007/s12094-021-02620-x

ISSN: 1699-048X